Literature DB >> 26621777

Taxodione and Extracts from Salvia austriaca Roots as Human Cholinesterase Inhibitors.

Łukasz Kuźma1, Halina Wysokińska1, Joanna Sikora2, Paulina Olszewska2, Elżbieta Mikiciuk-Olasik2, Paweł Szymański3.   

Abstract

Taxodione, an abietane diterpenoid, was isolated from Salvia austriaca transformed roots grown in in vitro conditions. The compound is known to have antibacterial, cytotoxic and anti-tumour properties. This study evaluates the ability of pure taxodione and extracts obtained from the S. austriaca hairy roots and roots from field-grown plants to inhibit human acetylcholinesterase and butyrylcholinesterase. Both extracts were found to have similar actions against acetylcholinesterase. The IC50 for extracts from transformed and untransformed roots were 142.5 and 139.5 µg ml(-1), respectively. The highest activity towards human acetylcholinesterase was demonstrated by taxodione (IC50  = 54.84 µg ml(-1)). With respect to BChE inhibition, the root extracts demonstrated stronger activity (IC50  = 23.6 µg ml(-1): field-grown plants and 41.6 µg ml(-1): transformed roots) than taxodione (IC50  = 195.9 µg ml(-1)). Taxodione showed significant cytotoxicity against A549 cell line (IC50  = 9.1 µg ml(-1)), whereas the activities for the extracts from S. austriaca roots of field-grown plants (IC50  = 75.7 µg ml(-1)) and hairy roots (IC50  = 86.2 µg ml(-1)) were lower. Computer modelling suggests that taxodione should not demonstrate cardiotoxic or genotoxic activity. It also indicates that taxodione should demonstrate very rapid transport from the body with very good blood-brain barrier penetration, but with no cumulative effect on the human body. The obtained results indicate that taxodione is a safe compound and may be used for further investigations in pharmacological activities.
Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Ellman method; cholinesterase inhibitors; diterpenoids; transformed roots

Mesh:

Substances:

Year:  2015        PMID: 26621777     DOI: 10.1002/ptr.5521

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  4 in total

1.  Metformin and Its Sulfenamide Prodrugs Inhibit Human Cholinesterase Activity.

Authors:  Magdalena Markowicz-Piasecka; Joanna Sikora; Łukasz Mateusiak; Elżbieta Mikiciuk-Olasik; Kristiina M Huttunen
Journal:  Oxid Med Cell Longev       Date:  2017-07-09       Impact factor: 6.543

Review 2.  Biologically Active Diterpenoids in the Clerodendrum Genus-A Review.

Authors:  Łukasz Kuźma; Jan Gomulski
Journal:  Int J Mol Sci       Date:  2022-09-20       Impact factor: 6.208

3.  Metformin and its sulphonamide derivative simultaneously potentiateanti-cholinesterase activity of donepezil and inhibit beta-amyloid aggregation.

Authors:  Magdalena Markowicz-Piasecka; Kristiina M Huttunen; Joanna Sikora
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

4.  Quetiapine and novel PDE10A inhibitors potentiate the anti-BuChE activity of donepezil.

Authors:  Joanna Sikora; Maria Podsiedlik; Tadeusz Pietras; Marcin Kosmalski; Mikołaj Matłoka; Rafał Moszczyński-Petkowski; Maciej Wieczorek; Magdalena Markowicz-Piasecka
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.